Manual Therapy and Quality of Life in People with
Headache: Systematic Review and Meta-analysis
of Randomized Controlled Trials

This section is compiled by Frank M. Painter, D.C.
Send all comments or additions to:

FROM:   Curr Pain Headache Rep 2019 (Aug 10); 23 (10): 78 ~ FULL TEXT

Luca Falsiroli Maistrello, Marco Rafanelli, Andrea Turolla

Department of Neuroscience, Rehabilitation,
Ophthalmology, Genetics, Maternal and Child Health,
University of Genova,
Campus of Savona, Savona, Italy.

Purpose of review:   People with headache usually experienced significantly lower health-related quality of life (HRQoL) than the healthy subjects. The goal of this systematic review was to evaluate the effectiveness of manual therapy on HRQoL in patients with tension-type headache (TTH), migraine (MH) or cervicogenic headache (CGH).

Recent findings:   We searched randomized controlled trials (RCTs) on MEDLINE, COCHRANE and PEDro databases. Treatment was manual therapy compared to usual care or placebo. The outcome was the HRQoL that could be measured by Headache Impact Test (HIT-6), Headache Disability Inventory (HDI), Migraine Disability Assessment Questionnaire (MIDAS) and Short Form Health Survey 12/36 (SF-12/36). For the RCT internal validity, we used the Cochrane risk of bias (RoB) tool. For the level of evidence, we used the Grading of Recommendations, Assessment, Development and Evaluation approach (GRADE).

We identified a total of 10 RCTs, 7 of which were included into the meta-analysis. For HIT-6 scale, meta-analysis showed statistically significant differences in favour to manual therapy both after treatment (mean difference (MD) - 3.67; 95% CI from - 5.71 to - 1.63) and at follow-up (MD - 2.47; 95% CI from - 3.27 to - 1.68). For HDI scale, meta-analysis showed statistically significant differences in favour to manual therapy both after treatment (MD - 4.01; 95% CI from - 5.82 to - 2.20) and at follow-up (MD - 5.62; 95% CI from - 10.69 to - 0.54). Other scales provided inconclusive results.

Manual therapy should be considered as an effective approach in improving the quality of life in patients with TTH and MH, while in patients with CGH, the results were inconsistent. Those positive results should be considered with caution due to the very low level of evidence. Researchers should in future design primary studies using valid and reliable disease-specific outcome measures.

Keywords:   Cervicogenic headache; HRQoL; Manual treatment; Migraine; Physical therapy; Tension-type.

From the FULL TEXT Article:


It is known that the quality of life in people suffering from headache is worse than in healthy subjects [1-3]; in addition, this high prevalence disorder has negative health consequences in terms of occupational, economic and social factors. [4] The first-line approach to the treatment of headaches is pharmacological; however, the chronicity of the disordermay increase the risk of incurring in drug abuse [5] or to develop a medicationoveruse headache (MOH). [6, 7] For these reasons, the use of non-pharmacological alternative practices like aerobic physical activity [8], behavioural interventions [9-11], physiotherapy and manual therapy [12-20] should also be considered [12, 17] even if the level of evidence is still low. [21, 22]

All recent literature reviews focused on the effectiveness of manual treatment in reducing the frequency, intensity and duration of attacks in headaches, especially on migraine (MH), tension-type headache (TTH) and cervicogenic headache (CGH) [13, 17–19, 23–25]; however, none of the aforementioned reviews performed a quantitative analysis of the results of manual treatments on patients’ quality of life. Considering the multifactorial nature of headache, it would be more correct to adopt a broader approach, evaluating the effects of treatments also on other factors such as pharmacological consumption, stress, patient satisfaction or expectations, disability and impact on the quality of life. [3, 26]

The aim of this systematic review was to research and summarize in a meta-analysis the results obtained on the quality of life in patients with headache when treated with manual therapy techniques compared to the pharmacological usual care or placebo.


This systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement (PRISMA). [27] Review protocol was registered on PROSPERO [28], code CRD42018106999.

      Inclusion Criteria

Only randomized controlled trials (RCTs) in Italian, English and Spanish were considered. The studies had to refer to adult subjects with TTH, MH or CGH diagnosis; the treatment had to be based on the manual therapy compared to pharmacological usual care or placebo. The studies had to report results on quality of life measured by at least one of the following scales: Headache Impact Test (HIT-6), Headache Disability Inventory (HDI), Migraine Disability Assessment Questionnaire (MIDAS), Short Form Health Survey 12 (SF-12) or 36 (SF-36).

      Exclusion Criteria

Studies that included only pharmacological treatment, botulinum toxin treatment, physiotherapy treatment without manual therapy or that compared two active treatments were excluded.

      Search Strategy

The literature search was performed by two independent authors (FML and RM) on MEDLINE, COCHRANE library and PEDro databases without any filter regarding author and year of publication (last search January 31, 2019). We considered any systematic reviews only to identify any primary study to be included in our review.

The keywords used were Headache, Migraine Disorders, Tension-Type Headache, Post-Traumatic Headache, Cervicogenic Headache, Musculoskeletal Manipulations, Physical Therapy Modalities, Physiotherapy, Manual Therapy, Soft Tissue*, Quality of Life, Dry needling, Acupressure and Clinical Trial, appropriately combined in the following search strings:

Medline (PubMed): (((“Headache”[Mesh]) OR “Migraine Disorders”[Mesh] OR “Tension-Type Headache”[Mesh] OR “Tension-Type Headache ” OR “Post-Traumatic Headache”[Mesh] OR “Cervicogenic Headache”)) AND (“Musculoskeletal Manipulations”[Mesh] OR “Physical Therapy Modalities”[Mesh] OR Physiotherapy OR “Manual Therapy” OR “Soft Tissue*” NOT (“dry needling” OR “acupressure”)) AND (“Quality of Life”[Mesh] OR Health) AND Clinical Trial [Publication Type] Cochrane (in trials): (((“Headache”) OR “Migraine Disorders” OR “Tension-Type Headache” OR “TensionType Headache” OR “Post-Traumatic Headache” OR “Cervicogenic Headache”)) AND (“Musculoskeletal Manipulations” OR “Physical Therapy Modalities” OR Physiotherapy OR “Manual Therapy” OR “Soft Tissue*” NOT (“dry needling” OR “acupressure”)) AND (“Quality of Life” OR Health) PEDro (simply search): “Headache” AND “Manual Therapy”

      Study Selection

Two independent authors (FML, RM) screened the records by title and abstract applying the eligibility criteria. At the end of the screening process, full-text articles were retrieved and assessed for their eligibility in the qualitative and/or quantitative synthesis. Any disagreement was resolved by consensus.

      Data Collection

Two authors (FML, RM) independently collected information from the included trials by ad hoc extraction form. The extracted data were organized in synoptic tables, including the following: author, year, design, duration, follow-up, sample size calculation, diagnosis, intervention, control, outcome (related to the quality of life), results. Any disagreements between reviewers were resolved by consensus. Measured results in the studies at the baseline and different follow-up were extracted; if necessary, the authors of the studies included were contacted. [29–31]

      Risk of Bias Assessment

The internal validity of the studies was independently assessed by two authors (FML, RM) using the Cochrane risk of bias (RoB) assessment tool. [32] The RoB for each study was assessed considering the following domains: selection bias (generation of random sequences and concealment of assignments), performance bias (blindness of participants and personnel), detection bias (blindness of evaluators), attrition bias (incomplete outcome data), reporting bias (selective reporting) and other sources of bias (sample size calculated on a different or unspecified outcome). [32] Each domain could be classified as “high”, “low” or “unclear” risk of bias according to study reporting, and any disagreement was resolved by consensus.

      Level of Evidence

We used the Grading of Recommendations, Assessment, Development and Evaluation approach (GRADE) to evaluate the overall quality of evidence based on the methodological quality of included trials. [33] The highest quality rating is for evidence based on high-quality RCTs; however, it is possible to downgrade this level of evidence if one of these factors is found in the included studies: study limitation, indirectness of evidence, unexplained heterogeneity or inconsistency of results, imprecision of results and high probability of publication bias. [34] Two authors (FML, RM) independently assessed the quality of the evidence; any disagreement between the authors was resolved by consensus. The GRADEPro GDT software was used. [35]

      Analysis and Synthesis of Results

Treatment effects for continuous outcome measures were evaluated by using the pooled mean difference (MD). The variance was expressed with 95% confidence intervals (95% CI). For the analysis, the studies were grouped according to the diagnostic class and outcome measure. The results from individual trials were combined in the metaanalysis using the fixed-effects models in case of absence of heterogeneity or random-effects models in the presence of heterogeneity. [36] Heterogeneity was analysed by the I2 statistic and the chI2 test; a value P < 0.05 indicated a statistically significant heterogeneity. [37]

For the meta-analyses, we firstly entered the mean values and standard deviations (SDs) measured after the intervention (post-treatment); secondly, we consider the values measured at the last available follow-up. To explore the influence of studies with high risk of bias that could lead to errors in the interpretation of the results of the meta-analysis [38], a sensitivity analysis was performed, excluding studies with at least two domains with high risk of bias. Studies that did not provide usable results for the quantitative assessment of outcomes were included in the review but excluded from the metaanalysis; the results of these studies have been treated in a descriptive way. When a trial presented multiple comparisons [39•, 40–42], the participants of the intervention or the comparison groups were equally distributed in two or more groups with smaller sample size, but equal means and SDs as suggested by Higgins et al. [43] in order to avoid a unit-ofanalysis error. The Cochrane Review Manager V5.3 software was used for meta-analysis. [44]


      Study Selection

Figure 1
see p. 4

We identified 206 records through database searching. After removing the duplicates, a total of 179 records were selected for screening. A total of 140 records were excluded after reading title and abstract. Of the 39 remaining articles, 29 were excluded after reading the full-text, while 10 articles were eligible for inclusion in the review [29–31, 39•, 40–42, 45–47]. Of these, 7 articles were included in the quantitative synthesis [30, 39•, 40–42, 45, 47] while 3were excluded from the quantitative synthesis [29, 31, 46] (Figure 1).

      General Study Characteristics

Table 1
see p. 5-6

We included 10 studies: 7 concerned TTH [29, 30, 39•, 40–42, 45], 2 MH [31, 47] and 1 involved a group of patients with mixed headaches (MH, TTH and CGH) [46] (Table 1).


The pooled population consisted of 728 subjects (mean age 40.9 ± 10.4 years) with a significant majority of women (582 out of 728, 80%).

The TTH subgroup consisted of 518 subjects (71.2% of the whole population) with a significant majority of women (423 out of 518, 81.7%). Three RCT concerned chronic TTH [29, 30, 46], four concerned episodic and chronic TTH [40–42, 45] and one considered both frequent-episodic and chronic TTH. [39•] The MH subgroup consisted of 160 subjects (22.0% of the whole population) with a majority of women (124 out of 160 77.5%). One RCT concerned MH with and without aura [31] and two chronic MH. [46, 47] In one trial [46], 4 subjects with CGH and 6 subjects with non-specified mixed headache were evaluated.


Headaches were diagnosed using the International Classification of Headache Disorders criteria (IHS) [48] except in one trial [31] that adopted the International Classification of Disease (ICD-10) criteria for the CGH subgroup. The diagnosis was usually performed by a neurologist; in one case, diagnosis was performed by a general practitioner [29] and one trial did not specify who made the diagnosis. [31]

Treatment and Sessions

The number of treatments ranged from 4 sessions in 4 weeks up to a maximum of 14 sessions in 6 months; the duration of the session ranged from 15' to 50'. The post-treatment/follow-up period ranged from a minimum of 2 weeks to a maximum of 9 months after the end of treatment.

Treatment Techniques

The treatments proposed in the studies included different techniques of manual therapy: articular mobilizations [30, 46], treatment of myofascial trigger points [29, 42], sub-occipital inhibitory pressures and manipulations of upper cervical levels [40, 41, 45], soft tissue techniques [31, 39, 47] and neuro-dynamic techniques. [39•]

Outcome Measure

Figure 2
see p. 7

Figure 3
see p. 8

Five trials used the HIT-6 scale [30, 39•, 40, 42, 47], four used the HDI scale [30, 40–42], one used the MIDAS scale [31], three used the SF-36 scale [29, 31, 46] and one used the SF-12 scale. [45]

Risk of Bias Within Studies

No attrition bias was detected in any study, but the blindness of the participants and personnel could not be achieved in any study, due to the nature of the manual treatment. Five studies had more than one high-risk domain of bias [29–31, 42, 46]. One study did not achieve the concealment of the assignment [31] while in four studies, the same risk was uncertain [40, 41, 45, 47]. Two studies were at high risk for detection bias, not having ensured the blindness of the evaluators [31, 42], while in four studies, the same risk was uncertain [29, 30, 40, 41]. Two studies did not completely report the values measured on patients for the outcome investigated [30, 31]. Regarding other sources of bias, five studies calculated the sample size using different outcomes and where considered as having high risk of sample selection bias [29–31, 42, 46]. Similarly in three studies [40, 41, 45], the same risk of bias was uncertain because the outcome on which the sample size was calculated was not specified (Figures. 2 and 3).

      Synthesis of the Results

The meta-analysis was conducted using the results obtained in the groups at the end of the treatment and at the follow-up; the studies were grouped by different scales and by clinical diagnosis (Figs. 4, 5, and 6).

Three studies that used the SF-36 scales were excluded from the meta-analysis because one used a customized version of the scale [46], one did not report the results [29] and one reported the values of the subscales but without the SDs [31]; the same study also used the MIDAS scale but without providing SD values.

Results on HIT-6 Scale

Figure 4
see p. 9

At the post-treatment, the meta-analysis included five studies for a total of 413 patients; two studies had high risk of bias on TTH [30, 42], two studies had low risk of bias on TTH [39•, 49] and one had low-risk of bias on MH. [47] In the TTH subgroup (N = 308), the analysis showed a significant difference in favour of the treatment but with high heterogeneity probably due to the different treatment techniques used, the different management of the control group and the presence of high risk of bias studies (MD – 2.85; 95%CI from – 4.90 at – 0.80; P = 0.006; 2 = 76%; Figure 4a). The heterogeneity dropped to a non-significant value when the two high risk of bias studies were excluded from the analysis [30, 42] (MD – 4.40; 95% CI from – 6.33 to – 2.48; P < 0.001; I2 = 43%; Fig. 4b). In the MH subgroup (N = 105), the results showed a significant difference in favour of the treatment (MD – 7.48; 95% CI from – 10.57 to – 4.39; P < 0.001; I2 = 0%); despite the absence of heterogeneity, the level of evidence remains low due to the presence of a single study. The combined results between the two subgroups showed a significant difference in favour of the treatment (MD – 3.67; 95% CI from – 5.71 to – 1.63; P < 0.001; I2 = 78%; Fig. 4a); also in this case, the heterogeneity decreased to non-significant values when the two studies at high risk of bias were excluded from the analysis [30, 42] (MD – 5.26; 95% CI from – 6.90 to – 3.63; P < 0.001; I2 = 42%; Fig. 4b). Despite the more robust results obtained from the sensitivity analysis, the overall level of evidence remains very low due to the high risk of bias of the most influential studies.

At the follow-up, the meta-analysis included four studies, two had high risk of bias [30, 42] and two had low risk of bias [39•, 49] for a total of 308 patients with TTH; the study on MH [47] did not show follow-up. The analysis showed a significant difference in favour of the treatment (MD – 2.47; 95% CI from – 3.27 to – 1.68; P < 0.001; I2 = 22%) and low heterogeneity; however, the level of evidence remained very low due to the presence of two studies with high risk of bias (Fig. 4c).

Results on HDI Scale

Figure 5
see p. 10

At the post-treatment, the meta-analysis included four studies, two had high risk of bias [30, 42] and two had low risk of bias [40, 41] for a total of 287 patients with TTH. The analysis showed a significant difference in favour of the treatment (MD – 4.01; 95% CI from – 5.82 to – 2.20; P = 0.02; I2 = 38%) with a very low level of evidence (Figure 5a).

At the follow-up, meta-analysis included three studies, two had high risk for bias [30, 42] and one had low risk of bias [40] for a total of 208 patients with TTH; one trial [40] did not present follow-up. The analysis showed a significant difference in favour of the treatment (MD – 5.62; 95% CI from – 10.69 to – 0.54; P = 0.03; I2 = 72%); the high heterogeneity was probably due to the different mechanism of action of joint mobilization techniques with respect to muscle techniques; the level of this evidence was very low (Fig. 5b).

Results on MIDAS Scale

Only one trial with high risk of bias [31] used the MIDAS scale on patients with MH. In the study, the comparison data between the groups at the follow-up for this outcome and the relative dispersion values (SD) are not reported; however, the authors found a significant decrease in the MIDAS score compared to the baseline only in the treatment group (from 37.6 to 24.8, P < 0.05) but not in the control group. The level of evidence is very low due to the high risk of bias and the presence of a single study.

Results on SF-36 Scale

Three trials with high risk of bias used SF-36 scale. [29, 31, 46] Uthaikhup et al. [46] analysed the results on a group of 65 elderly patients with mixed headaches, MH, TTH and CGH. The eight domains of the SF-36 scale were grouped into a physical component summary score (PCS) and mental component summary score (MCS). The measured PCS values showed a mean difference of 25.3 points (from 19.2 to 31.4; 95% CI; P < 0.001) to posttreatment and 23.4 points (from 17.6 to 29.2; 95% CI; P < 0.001) to the follow-up to 9 months for the treatment group. Similarly, the MCS showed a mean difference of 21.6 points (from 16.0 to 27.2; 95% CI; P < 0.001) to post-treatment and 17.9 points (from 11.6 to 24.2; 95% CI; P < 0.001) to the follow-up of 9 months. In contrast, the study conducted on 39 subjects with TTH by Berggren et al. [29] reported no significant difference between post-treatment and follow-up groups for any of the items on the scale, but the values were not reported in the study. Voigt et al. [31] on a sample of 42 subjects with MH reported significant improvements in the treatment group only in the vitality, mental health, physical pain, role and physical activity items (P < 0.05) while the results on the other items did not reach significance statistics; the data reported by the authors did not allow a comparison between the results obtained to the posttreatment due to the lack of dispersion indices. The level of this evidence was very low.

Results on SF-12 Scale

Figure 6
see p. 11

Only one trial with high risk of bias [45] conducted on 76 subjects with TTH did not report significant differences in the SF-12 score between the groups neither to post-treatment (Figure 6a) nor to follow-up (Fig. 6b). The authors found a significant improvement with respect to baseline only in the group receiving sub-occipital inhibition while separate analyses for domains revealed different results depending on the item considered. The best results were observed in the group receiving the combined treatment, both post-treatment and follow-up. The authors concluded that the manual techniques applied to the sub-occipital region for a minimum of 4 weeks could offer a positive improvement only in some aspects of the quality of life of the patient’s life, but the level of evidence was very low because of presence of a single study.


The purpose of this review was to investigate the effectiveness of manual therapy on the health-related quality of life in patients with headache. On a total of 10 included studies, 7 concerned TTH [29, 30, 39•, 40–42, 45], 2 MH [31, 47] and 1 involved a group of patients with mixed headaches,MH, TTH and CGH. [46] The entire sample consisted of 728 subjects, 80% of whom were women; this data could make the results less generalizable; however, several studies have confirmed that the female gender could constitute a risk factor for the headaches, in particular for MH and TTH. [50, 51]

Except for a few exceptions, manual therapy obtained more positive effect on quality of life compared to usual care or placebo when measured by the HIT-6 and HDI diseasespecific scales in patients with TTH or MH [39•, 47]; however, only the HIT-6 scale results reached the minimal clinical important difference. [62] These positive results are consistent with those obtained in a previous narrative review that investigated the general effects of manual therapy on patients with TTH. [20] Instead, the results obtained on CGH are to be taken with reserve: in fact, his type of disorder was included only in one study [46] where groups were composed by patients with different types of headache (MH, TTH, CGH and mixed). Authors reported a general improvement in the treatment group compared to control, but the results obtained on the CGH subgroup could not be extracted.

In some cases, a trend in favour of the control group has been noted. Moraska et al. reported better results in the group that received the placebo but this trend was noted only post treatment and was not statistically significant [42]; this positive trend was not maintained at follow-up. In three trials conducted by Espi Lopez et al. [40, 41, 45], all treatment and control groups reported significant improvement with respect to baseline but betweengroup differences were not significant. Unlike the other studies included in the review that used classical placebo groups [39•, 42, 47], in those cases, authors have tried to guarantee a rigorous control of contextual factors, giving to the control group (who received no active treatment or placebo) the same conditions of the treatment group in terms of number of sessions, frequency and duration. These particular types of control group (sometimes called attention control groups [55]) seemed to be as effective as conventional placebo. [40] These apparently inconclusive results could be explained not only by the different effectiveness of the manual therapy techniques adopted, but also by the different management of the contextual conditions, supporting the idea that not only the nature of intervention but also the setting in which the treatment is performed is important, due to the influence of the context on manual treatments. Factors like the time dedicated to the patient, interaction and human relationship [42, 56] should be adequately balanced among all the groups of subjects involved in the studies [57]; an adequate control of contextual factors could actually affect the overall effect of manual therapy, which is sensitive to both the placebo and the nocebo effect. [58**]

The results obtained by the MIDAS and SF-36 scales have been tendentially positive compared to the baseline values for most of the groups; also in this case, manual therapy techniques seem to have a certain influence on different aspects of quality of life in people with TTH, especially in functional aspects. However, only one study reported clearly beneficial effects of treatment [46] while data from the other studies were not comparable in the meta-analysis. [29, 31] Regarding the SF-12 scale, between-group comparisons showed no significant differences even if the trend was positive for both when compared to the baseline. [45] These conditions and the lack of data do not allow us to claim with any certainty that manual therapy, in this case, was more effective than usual care or placebo.

It seems that the measure of the effectiveness of manual techniques could depend on the method used to evaluate the quality of life, as the best results were found when diseasespecific scales were used. According to Haywood et al. [59**], the use of valid and specific scales like HIT-6 should be considered both in research studies and in clinical approaches; in fact, generic assessment scales like SF-12 or SF-36 may not be appropriate for evaluating patients with TTH and MH headaches [60-62] even if they could represent a valid support to the disease-specific scales. Combining generic and diseasespecific tools would make possible to obtain a general overview of the impact of the disease on patients, making the results comparable with other disorders. [26]


The present review has some limitations: first, the inclusion criteria were limited to only three languages; secondly, in the studies with more than two comparisons, the need to split the shared group into two or more groups with smaller sample size (in order to avoid a double-counting error according to the indications of the Cochrane Handbook [43]) may have reduced the power of the meta-analysis results.


Manual therapy has shown better effects compared to usual care and placebo in terms of quality of life patients with tension-type headache (TTH) and migraine (MH) , but the results should be taken with caution due to the very low level of evidence and high risk of bias of the most influential studies. In patients with cervicogenic headache (CGH), the results are inconsistent, and there is a need to make new specific studies for this type of headache. In the face of significant improvements compared to baseline and the absence of adverse effects, manual therapy should, therefore, be considered as a valid approach, being able to positively affect the quality of life of patients with headache. To increase the level of evidence, researchers should in future design primary studies that provide appropriate control groups and follow-up periods, using valid and reliable disease-specific outcome measures.


Special thanks to Dr. Andrea Dell’Isola for his precious help and for his contribution in the finalization phase of the present review.

Conflict of Interest

Luca Falsiroli Maistrello, Marco Rafanelli and Andrea Turolla declare no conflict of interest.



Papers of particular interest, published recently, have been highlighted as:
* Of importance
** Of major importance

  1. Becker WJ.
    Assessing health-related quality of life in patients with migraine.
    Can J Neurol Sci. 2002;29(Suppl 2):S16–22.

  2. Disease GBD;
    Global, Regional, and National Incidence, Prevalence, and Years Lived With
    Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016:
    A Systematic Analysis for the Global Burden of Disease Study 2016

    Lancet. 2017 (Sep 16); 390 (10100): 1211–1259

  3. Abu Bakar N, Tanprawate S, Lambru G, Torkamani M, Jahanshahi M.
    Quality of life in primary headache disorders: a review.
    Cephalalgia. 2016;36:67–91.

  4. Allena M, Steiner TJ, Sances G, Carugno B, Balsamo F, et al.
    Impact of headache disorders in Italy and the public-health and policy
    implications: a population-based study within the Eurolight project.
    J Headache Pain. 2015;16:100.

  5. Kristoffersen ES, Grande RB, Aaseth K, Lundqvist C, Russell MB.
    Management of primary chronic headache in the general population:
    the Akershus study of chronic headache.
    J Headache Pain. 2012;13:113–20.

  6. Sinclair AJ, Sturrock A, Davies B, Matharu M.
    Headache management: pharmacological approaches.
    Pract Neurol. 2015;15:411–23.

  7. LindeM, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, et al.
    The cost of headache disorders in Europe: the Eurolight project.
    Eur J Neurol. 2012;19:703–11.

  8. Sertel M, Bakar Y, Simsek TT.
    The effect of body awareness therapy and aerobic exercises on pain
    and quality of life in the patients with tension type headache.
    Afr J Tradit Complement Altern Med. 2017;14:288–310.

  9. Day MA, Thorn BE, Rubin NJ.
    Mindfulness-based cognitive therapy for the treatment of headache pain:
    a mixed-methods analysis comparing treatment responders and treatment non-responders.
    Complement Ther Med. 2014;22:278–85.

  10. Sun-Edelstein C, Mauskop A.
    Alternative Headache Treatments:
    Nutraceuticals, Behavioral and Physical Treatments

    Headache J Head Face Pain. 2011 (Mar); 51 (3): 469-83

  11. Koushede V, Hansen EH, Andersen A, Holstein BE.
    Young adults’ medicine use for headache: the combined effect of socioeconomic
    position and perceived stress, and the contribution of sense of coherence.
    Res Soc Adm Pharm. 2012;8:533–41.

  12. Bronfort G, Nilsson N, Haas M, et al.
    Non-invasive Physical Treatments for Chronic/Recurrent Headache
    Cochrane Database Syst Review 2004; (3): CD001878
    Update in: Cochrane Database Syst Rev. 2014;8: CD001878.

  13. Lenssinck MLB, Damen L, Verhagen AP, Berger MY, Passchier J, Koes BW.
    The effectiveness of physiotherapy and manipulation
    in patients with tension-type headache: a systematic review.
    Pain. 2004;112:381–8.

  14. Bodes-Pardo G, Pecos-Martín D, Gallego-Izquierdo T, Salom-Moreno J.
    Manual Treatment for Cervicogenic Headache and Active Trigger Point
    in the Sternocleidomastoid Muscle: A Pilot Randomized Clinical Trial

    J Manipulative Physiol Ther. 2013 (Sep); 36 (7): 403—411

  15. Fernández-de-Las-Peñas C, Alonso-Blanco C, CuadradoML, et al.
    Are manual therapies effective in reducing pain from
    tension-type headache?: a systematic review.
    Clin J Pain. 006;22:278–85.

  16. Chaibi A, Tuchin PJ, Russell MB.
    Manual Therapies for Migraine: A Systematic Review
    J Headache Pain. 2011 (Apr); 12 (2): 127–133

  17. A. Chaibi, M.B. Russell
    Manual Therapies for Primary Chronic Headaches:
    A Systematic Review of Randomized Controlled Trials

    J Headache Pain. 2014 (Oct 2); 15: 67

  18. Posadzki P, Ernst E.
    Spinal manipulations for cervicogenic headaches:
    a systematic review of randomized clinical trials.
    Headache. 2011;51:1132–9.

  19. Chaibi A, Russell MB.
    Manual Therapies for Cervicogenic Headache:
    A Systematic Review

    J Headache Pain. 2012 (Jul); 13 (5): 351–359

  20. Lozano López C, Mesa Jiménez J, de la Hoz Aizpurúa JL, et al.
    Efficacy of manual therapy in the treatment of tension-type headache.
    A systematic review from 2000-2013.
    Neurologia. 2016;31(6):357–69.

  21. Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, et al.
    EFNS guideline on the treatment of tension-type headache—
    report of an EFNS task force.
    Eur J Neurol. 2010;17:1318–25.

  22. NICE Clinical Guideline (CG150)
    Headaches in Over 12s: Diagnosis and Management
    NICE Guideline, No. 150
    London: National Institute for Health and Care Excellence (NICE);
    2021 Dec 17. ISBN-13: 978-1-4731-1533-0

  23. Falsiroli Maistrello L, Geri T, Gianola S, Zaninetti M, Testa M.
    Effectiveness of trigger point manual treatment on the frequency,
    intensity, and duration of attacks in primary headaches:
    a systematic review and meta-analysis of
    randomized controlled trials.
    Front Neurol. 2018;9(APR).

  24. Luedtke K, Allers A, Schulte LH, et al.
    Efficacy of interventions used by physiotherapists for patients with
    headache and migraine — systematic review and meta-analysis.
    Cephalalgia. 2015;0:1–19.

  25. Fernández-de-Las-Peñas C, Cuadrado ML.
    Physical therapy for headaches.
    Cephalalgia. 2015;0:0333102415596445.

  26. Andrasik F, Lipchik GL, McCrory DC, et al.
    Outcome measurement in behavioral headache research:
    headache parameters and psychosocial outcomes.
    Headache. 2005;45:429–37.

  27. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, et al.
    The PRISMA statement for reporting systematic reviews and meta-analyses
    of studies that evaluate health care interventions: explanation and elaboration.
    PLoS Med. 2009;6(7).

  28. Falsiroli Maistrello L, Rafanelli M, Turolla A.
    Do manual therapy techniques have more positive effect compared to usual care on
    quality of life in people with headaches? A systematic review and
    meta-analysis of randomized controlled trials. PROSPERO. 2018:
    CRD42018106999. Available from:
    Accessed 30 Aug 2018.

  29. Berggreen S, Wiik E, Lund H.
    Treatment of myofascial trigger points in female patients with
    chronic tension-type headache—a randomized controlled trial.
    Adv Physiother. 2012;14:10–7.

  30. Castien, R. F., van der Windt, D. A., Grooten, A., & Dekker, J.
    Effectiveness of Manual Therapy for Chronic Tension-type Headache:
    A Pragmatic, Randomised, Clinical Trial

    Cephalalgia. 2011 (Jan); 31 (2): 133–143

  31. Voigt K, Liebnitzky J, Burmeister U, Sihvonen-Riemenschneider H, et al.
    Efficacy of osteopathic manipulative treatment of female patients
    with migraine: results of a randomized controlled trial.
    J Altern Complement Med. 2011;17:225–30.

  32. Higgins JP, Green S.
    Cochrane handbook for systematic reviews of interventions.
    Version 5.1.0. In: Higgins JP, Green S, editors.
    The Cochrane Collaboration; 2011.

  33. Schünemann HJ, Oxman AD, Brozek J, et al.
    GRADE: assessing the quality of evidence for diagnostic recommendations.
    Evid Based Med. 2008;13:162–3.

  34. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al.
    GRADE: an emerging consensus on rating quality of evidence
    and strength of recommendations.
    BMJ. 2008;336:924–6.

  35. Schünemann HJ BJ.
    GRADEpro Guideline Development Tool. 2015.

  36. DerSimonian R, Laird N.
    Meta-analysis in clinical trials.
    Control Clin Trials. 1986;7:177–88.

  37. Higgins JPT, Thompson SG, Deeks JJ, Altman DG.
    Measuring inconsistency in meta-analyses.
    BMJ Br Med J. 2003;327:557–60.

  38. Higgins JP, Altman DG, Sterne J.
    Chapter 8: assessing risk of bias in included studies.
    In: Higgins JP, Green S, editors. Cochrane Handb. Syst.
    Rev. Interv. version 5.1.0.
    The Cochrane Collaboration; 2011.

  39. * Ferragut-Garcías A, Plaza-Manzano G, Rodríguez-Blanco C, et al.
    Effectiveness of a treatment involving soft tissue techniques and/or
    neural mobilization techniques in the management of the
    tension-type headache: a randomized controlled trial.
    Arch Phys Med Rehabil. 2016;98:211–219.e2
    A very well conducted RCT that used quality of life as primary outcome.

  40. Espí-López GV, Gómez-Conesa A, Gómez AA, Martínez JB, Pascual-Vaca ÁO.
    Treatment of tension-type headache with articulatory and suboccipital
    soft tissue therapy: a double-blind, randomized, placebo-controlled clinical trial.
    J Bodyw Mov Ther. 2014;18:576–85.

  41. Espí-López GV, Rodriguez-Blanco C, Oliva-Pascual-Vaca A, et al.
    Effect of manual therapy techniques on headache disability in patients
    with tension-type headache. Randomized controlled trial.
    Eur J Phys Rehabil Med. 2014;50:641–7.

  42. Moraska AF, Stenerson L, Butryn N, Krutsch JP, Schmiege SJ, Mann JD.
    Myofascial trigger point-focused head and neck massage
    for recurrent tension-type headache.
    Clin J Pain. 015;31:159–68.

  43. Higgins JP, Deeks JJ, Altman DG.
    Chapter 16: special topics in statistics.
    In: Higgins JP, Green S, editors. Handb. Syst.
    Rev. Interv. Version 5.1.0.
    The Cochrane Collaboration; 2011.

  44. The Cochrane Collaboration.
    Review Manager (RevMan) V.5.3.
    Copenhagen: the Nordic Cochrane Center; 2014.

  45. Espi-Lopez GV, Rodríguez-Blanco C, Oliva-Pascual-Vaca Á, et al.
    Do manual therapy techniques have a positive effect on quality of life
    in people with tension-type headache? A randomized controlled trial.
    Eur J Phys Rehabil Med. 2016;52:447–56.

  46. Uthaikhup S, Assapun J, Watcharasaksilp K, Jull G.
    Effectiveness of physiotherapy for seniors with recurrent headaches associated with
    neck pain and dysfunction: a randomized controlled trial.
    Spine J. 2017;17:46–55.

  47. Cerritelli F, Ginevri L, Messi G, Caprari E, di Vincenzo M, et al.
    Clinical effectiveness of osteopathic treatment in chronic migraine: 3-armed randomized controlled trial.
    Complement Ther Med. 2015;23:149–56.

  48. Vincent M, Wang S.
    Headache Classification Committee of the International Headache Society
    (IHS) The International Classification of Headache Disorders, 3rd edition.
    Cephalalgia. 2018;38:1–211.

  49. Espi-Lopez GV, Rodriguez-Blanco C, Oliva-Pascual-Vaca A, Benitez-Martinez JC.
    Effect of Manual Therapy Techniques on Headache Disability in Patients
    With Tension-type Headache. Randomized Controlled Trial

    Eur J Phys Rehabil Med. 2014 (Dec); 50 (6): 641–647

  50. Ailani J.
    Tension-type headache and women: do sex hormones
    influence tension-type headache?
    Curr Pain Headache Rep. 2010;14:436–40.

  51. Burch RC, Loder S, Loder E, Smitherman TA.
    The prevalence and burden of migraine and severe headache in the United States:
    updated statistics from government health surveillance studies.
    Headache J Head Face Pain. 2015;55:21–34.

  52. Smelt AFH, Assendelft WJJ, Terwee CB, Ferrari MD, Blom JW.
    What is a clinically relevant change on the HIT-6 questionnaire?
    An estimation in a primary-care population of migraine patients.
    Cephalalgia. 2014;34:29–36.

  53. Castien RF, Blankenstein AH, van der Windt DA, et al.
    Minimal clinically important change on the Headache Impact Test-6
    questionnaire in patients with chronic tension-type headache.
    Cephalalgia. 2012;32:710–4.

  54. Coeytaux RR, Kaufman JS, Chao R, Mann JD, DeVellis RF.
    Four methods of estimating the minimal important difference score
    were compared to establish a clinically significant change
    in Headache Impact Test.
    J Clin Epidemiol. 2006;59:374–80.

  55. Kamper SJ.
    Blinding: linking evidence to practice.
    J Orthop Sport Phys Ther. 2018;48:825–6.

  56. Rossettini G, Carlino E, Testa M.
    Clinical relevance of contextual factors as triggers of
    placebo and nocebo effects in musculoskeletal pain.
    BMC Musculoskelet Disord. 2018;19:27.

  57. Rossettini G, Testa M.
    Manual therapy RCTs: should we control placebo in placebo control?
    Eur J Phys Rehabil Med. 2018;54(3): 500–501.

  58. ** Testa M, Rossettini G.
    Enhance placebo, avoid nocebo:
    how contextual factors affect physiotherapy outcomes.
    Man Ther. 2016;24: 65–74
    The first article that analyses the importance of contextual factors in physiotherapy.

  59. ** Haywood KL,Mars TS, Potter R, Patel S, Matharu M, Underwood M.
    Assessing the impact of headaches and the outcomes of treatment:
    a systematic review of patient-reported outcome measures (PROMs).
    Cephalalgia. 2018 (Jun); 38 (7): 1374–86.
    A good systematic review focused on the different methods available to measure the impact of headaches on quality of life.

  60. Lipton R, Kolodner K, Bigal M, Valade D, Láinez MJA, Pascual J, et al.
    Validity and reliability of the migraine-treatment optimization questionnaire.
    Cephalalgia. 2009;29:751–9.

  61. De Diego EV, Lanteri-Minet M.
    Recognition and management of migraine in primary care:
    influence of functional impact measured by the Headache Impact Test (HIT).
    Cephalalgia. 2005;25:184–90.

  62. Magnusson JE, Riess CM, Becker WJ.
    Modification of the SF-36 for a headache population changes
    patient-reported health status.
    Headache. 2012;52:993–1004.

Return to HEADACHE

Since 2-06-2023

                  © 1995–2023 ~ The Chiropractic Resource Organization ~ All Rights Reserved